Clínica Baviera, S.A. (BME:CBAV)
Spain · Delayed Price · Currency is EUR 56.40
+0.60 (1.08%)
May 18, 2026, 1:56 PM CET
Clínica Baviera Market Cap
Clínica Baviera has a market cap or net worth of €893.83 million as of May 18, 2026. Its market cap has increased by 48.64% in one year.
Market Cap
893.83M
Enterprise Value
913.64M
Revenue
304.91M
Ranking
n/a
PE Ratio
21.24
Stock Price
€56.40
Market Cap Chart
Since April 10, 2007, Clínica Baviera's market cap has increased from 369.53M to 893.83M, an increase of 141.88%. That is a compound annual growth rate of 4.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 893.83M | 12.32% |
| Dec 31, 2025 | 795.80M | 59.55% |
| Dec 31, 2024 | 498.78M | 33.02% |
| Dec 29, 2023 | 374.97M | 31.81% |
| Dec 30, 2022 | 284.48M | -17.68% |
| Dec 30, 2021 | 345.60M | 50.35% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Grifols | 5.57B |
| Laboratorios Farmaceuticos Rovi | 3.02B |
| Almirall | 2.43B |
| Pharma Mar | 1.67B |
| Faes Farma | 1.43B |
| Prim, S.A. | 221.18M |
| Laboratorio Reig Jofre | 220.63M |
| Oryzon Genomics | 218.12M |